Skip to content

Clinical Study of Targeted Interferon Stimulating Gene (STING) Molecular Probe

Clinical Study of Targeted Interferon Stimulating Gene (STING) Molecular Probe

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115285
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

18F-FBTA:Inject molecular probe 18F-FBTA

Sponsors

The First Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old, male or female not limited; 2.Research participants have behavioral capacity, understand and have voluntarily signed informed consent forms; 3.Patients initially diagnosed with malignant tumors or previously diagnosed with malignant tumors, and/or those planning to undergo immunotherapy;

Exclusion criteria

Exclusion criteria: 1.Critically ill patients requiring emergency treatment; 2.Drug and/or alcohol abusers, individuals with allergies; 3.Pregnant, lactating, and pre pregnancy women; 4.There are bacterial, viral, or fungal infections that require systemic treatment; 5.Participants deemed unsuitable by researchers;

Design outcomes

Primary

MeasureTime frame
SUVmax;

Countries

China

Contacts

Public ContactWei Fu

The First Affiliated Hospital of Guilin Medical University

13977385850@126.com+86 13977385850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026